Washington experts patient Washington

FDA approves much-debated Alzheimer’s drug Biogen, 1st in nearly 20 years

Reading now: 887
www.fox29.com

WASHINGTON - Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.The Food and Drug Administration said it granted approval to the drug developed by Biogen for patients with Alzheimer's disease.It’s the only drug that U.S.

regulators have said can likely treat the underlying disease, rather than manage symptoms like anxiety and insomnia.The decision, which could impact millions of older Americans and their families, is certain to spark disagreements among physicians, medical researchers and patient groups.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA